These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32940072)

  • 21. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial.
    Hermida RC; Crespo JJ; Domínguez-Sardiña M; Otero A; Moyá A; Ríos MT; Sineiro E; Castiñeira MC; Callejas PA; Pousa L; Salgado JL; Durán C; Sánchez JJ; Fernández JR; Mojón A; Ayala DE;
    Eur Heart J; 2020 Dec; 41(48):4565-4576. PubMed ID: 31641769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.
    Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
    Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study.
    Portaluppi F; Smolensky MH
    Chronobiol Int; 2010 Sep; 27(8):1652-67. PubMed ID: 20854140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronotherapy of cardiac and vascular disease: timing medications to circadian rhythms to optimize treatment effects and outcomes.
    Smolensky MH; Hermida RC; Geng YJ
    Curr Opin Pharmacol; 2021 Apr; 57():41-48. PubMed ID: 33279870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications.
    Ayala DE; Hermida RC; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension: New perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk.
    Hermida RC; Ayala DE; Fernández JR; Mojón A; Smolensky MH
    Eur J Clin Invest; 2018 May; 48(5):e12909. PubMed ID: 29423914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bedtime hypertension chronotherapy: concepts and patient outcomes.
    Smolensky MH; Hermida RC; Ayala DE; Portaluppi F
    Curr Pharm Des; 2015; 21(6):773-90. PubMed ID: 25341856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
    Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of incident chronic kidney disease is better reduced by bedtime than upon-awakening ingestion of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Hypertens Res; 2018 May; 41(5):342-353. PubMed ID: 29531290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):328-39. PubMed ID: 23181738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bedtime Chronotherapy with Conventional Hypertension Medications to Target Increased Asleep Blood Pressure Results in Markedly Better Chronoprevention of Cardiovascular and Other Risks than Customary On-awakening Therapy.
    Smolensky MH; Hermida RC; Ayala DE; Mojón A; Fernández JR
    Heart Fail Clin; 2017 Oct; 13(4):775-792. PubMed ID: 28865784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bedtime Blood Pressure Chronotherapy Significantly Improves Hypertension Management.
    Hermida RC; Ayala DE; Fernández JR; Mojón A; Crespo JJ; Ríos MT; Smolensky MH
    Heart Fail Clin; 2017 Oct; 13(4):759-773. PubMed ID: 28865783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults.
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F
    Chronobiol Int; 2015; 32(10):1329-42. PubMed ID: 26587588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Diabetologia; 2016 Feb; 59(2):255-65. PubMed ID: 26399404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current evidence on the circadian-time-dependent effects of hypertension medications and their combinations in relation to findings of MAPEC and Hygia Chronotherapy Trial.
    Hermida RC; Fernández JR; Mojón A
    Chronobiol Int; 2020 May; 37(5):751-758. PubMed ID: 32683989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronotherapeutics of conventional blood pressure-lowering medications: simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders.
    Hermida RC; Ayala DE; Smolensky MH; Fernández JR; Mojón A; Crespo JJ; Ríos MT; Moyá A; Portaluppi F
    Curr Hypertens Rep; 2014 Feb; 16(2):412. PubMed ID: 24407445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension.
    Smolensky MH; Hermida RC; Ayala DE; Tiseo R; Portaluppi F
    Blood Press Monit; 2010 Aug; 15(4):173-80. PubMed ID: 20571367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients.
    Hermida RC; Ayala DE; Chayan L; Mojon A; Fernandez JR
    Chronobiol Int; 2009 Jan; 26(1):61-79. PubMed ID: 19142758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.